Sodium bicarbonate - known medication, new prospects?

Anna Lis; Paulina Lis; Wojciech Kaźmierski; Kinga Kocur; Katarzyna Camlet; Jakub Jurek; Mateusz Ziomek; Anna Ziobro

doi:10.56782/pps.249

Published : 2024-09-24

Vol. 22 No. 3 (2024)

Sodium bicarbonate - known medication, new prospects?

Anna Lis

Paulina Lis

Wojciech Kaźmierski

Kinga Kocur

Katarzyna Camlet

Jakub Jurek

Mateusz Ziomek

Anna Ziobro

DOI: https://doi.org/10.56782/pps.249

Abstract

Critical conditions frequently involve disturbances in blood gas analysis and electrolyte imbalances. Sodium bicarbonate has seen expanded medical use in recent years. The European Resuscitation Council (ERC) Guidelines endorse sodium bicarbonate for hyperkalemia, malignant hyperthermia, and specific drug intoxications. Its potential roles in treating intracranial hypertension and symptomatic hyponatremia are also being explored. However, its application in emergency departments (ED) remains inconsistent, particularly in profound metabolic acidosis cases. We conducted a review of sodium bicarbonate’s therapeutic uses. The evolving understanding of sodium bicarbonate's role in emergency medicine and intensive care highlights both its potential applications and associated risks. While not universally beneficial, especially in lactic acidosis, it may aid specific patient subgroups, such as those with acute kidney injury. Its use in hyperkalemia, intracranial hypertension and diabetic ketoacidosis (DKA) also presents mixed results, with potential benefits in particular contexts. Further large-scale, randomized controlled trials are needed to develop precise guidelines, ensuring its safe and effective use tailored to individual patient needs.

Keywords:

bicarbonate, lactic acidosis, hyperkalemia, diabetic ketoacidosis, intracranial hypertension

Similar Articles

Adam Piasecki, Magdalena Sitnik, Jakub Olszewski, Maciej Bara, Katarzyna Herjan, Piotr Armański, The changing landscape of mineralocorticoid receptor antagonists – finerenone in cardiovascular and renal health , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
Iwona Lewandowska Lewandowska, Monika Zielińska-Pisklak, Łukasz Szeleszczuk, Dariusz Maciej Pisklak, Marcin Sobczak, PULMONARY HYPERTENSION — PATHOPHYSIOLOGY AND DRUGS USED IN THERAPY , Prospects in Pharmaceutical Sciences: Vol. 18 No. 2 (2020)
Paulina Wilczyńska, Barbara Lisowska-Myjak, ROLA AMINOPEPTYDAZ ŁOŻYSKOWYCH W PRZEBIEGU CIĄŻY , Prospects in Pharmaceutical Sciences: Vol. 17 No. 1 (2019)
Zofia Suchocka, OBESITY - REASONS AND TREATMENT , Prospects in Pharmaceutical Sciences: Vol. 1 No. 1 (2003)
Sylwia Kraczkowska, Zofia Suchocka, Jan Pachecka, ELEVATED BLOOD LEVEL OF HOMOCYSTEINE AS INDICATOR OF HEALTH HAZARD , Prospects in Pharmaceutical Sciences: Vol. 3 No. 3 (2005)
Karolina Nowakowska, EPIDEMIOLOGY, CLASSIFICATION AND DIAGNOSIS OF FUNCTIONING AND NONFUNCTIONING PITUITARY ADENOMAS , Prospects in Pharmaceutical Sciences: Vol. 13 No. 6 (2015)
Falah Saleh Mohammed, Mustafa Sevindik, İmran Uysal, Ali Erdem Sabik, Quercetin: derivatives, biosynthesis, biological activity, pharmacological and therapeutic effects , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
Aleksandra Ziółkowska, Szymon Wojtaszek, Bogdan Fels, Unraveling the weight of emotions: a comprehensive review of the interplay between depression and obesity , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF

Citation rules

Lis, A., Lis, P., Kaźmierski, W., Kocur, K., Camlet, K., Jurek, J., … Ziobro, A. (2024). Sodium bicarbonate - known medication, new prospects?. Prospects in Pharmaceutical Sciences, 22(3), 198–203. https://doi.org/10.56782/pps.249

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

Wardi, G.; Holgren, S.; Gupta, A.; Sobel, J.; Birch, A.; Pearce, A.; Malhotra, A.; Tainter, C. A Review of Bicarbonate Use in Common Clinical Scenarios. J. Emerg. Med. 2023, 65, e71-e80. DOI: 10.1016/j.jemermed.2023.04.012.

Lott, C.; Truhlář, A.; Alfonzo, A.; Barelli, A.; González-Salvado, V.; Hinkelbein, J.; Nolan, J.P.; Paal, P.; Perkins, G.D.; Thies, K.C.; Yeung, J.; Zideman, D.A.; Soar, J. European Resuscitation Council Guidelines 2021: Cardiac Arrest in Special Circumstances. Resuscitation 2021, 161, 152-219. DOI: 10.1016/j.resuscitation.2021.02.011.

Adeva-Andany, M.M.; Fernández-Fernández, C.; Mouriño-Bayolo, D.; Castro-Quintela, E.; Domínguez-Montero, A. Sodium Bicarbonate Therapy in Patients with Metabolic Acidosis. Sci. World J. 2014, 2014, Art. No: 627673. DOI: 10.1155/2014/627673.

Zeiler, F.A.; Sader, N.; West, M.; Gillman, L.M. Sodium Bicarbonate for Control of ICP: A Systematic Review. J. Neurosurg. Anesthesiol. 2018, 30, 2-9. DOI: 10.1097/ANA.0000000000000373.

Bourdeaux, C.P.; Brown, J.M. Randomized Controlled Trial Comparing the Effect of 8.4% Sodium Bicarbonate and 5% Sodium Chloride on Raised Intracranial Pressure after Traumatic Brain Injury. Neurocrit. Care 2011, 15, 42-45. DOI: 10.1007/s12028-011-9512-0.

Coppola, S.; Caccioppola, A.; Froio, S.; Chiumello, D. Sodium Bicarbonate in Different Critically Ill Conditions: From Physiology to Clinical Practice. Anesthesiology 2021, 134, 774-783. DOI: 10.1097/ALN.0000000000003733.

Sterns, R.H.; Grieff, M.; Bernstein, P.L. Treatment of Hyperkalemia: Something Old, Something New. Kidney Int. 2016, 89, 546-554. DOI: 10.1016/j.kint.2015.11.018.

Dépret, F.; Peacock, W.F.; Liu, K.D.; Rafique, Z.; Rossignol, P.; Legrand, M. Management of Hyperkalemia in the Acutely Ill Patient. Ann. Intensive Care 2019, 9, Art. No: 32. DOI: 10.1186/s13613-019-0509-8.

Redant, S.; Hussein, H.; Mugisha, A.; Attou, R.; De Bels, D.; Honore, P.M.; De Laet, C.C. Differentiating Hyperlactatemia Type A from Type B: How Does the Lactate/Pyruvate Ratio Help? J. Transl. Int. Med. 2019, 7, 43-45. DOI: 10.2478/jtim-2019-0010.

Wardi, G.; Brice, J.; Correia, M.; Liu, D.; Self, M.; Tainter, C. Demystifying Lactate in the Emergency Department. Ann. Emerg. Med .2020, 75, 287-298. DOI: 10.1016/j.annemergmed.2019.06.027.

Forsythe, S.M.; Schmidt, G.A. Sodium Bicarbonate for the Treatment of Lactic Acidosis. Chest 2000, 117, 260-267. DOI: 10.1378/chest.117.1.260.

Kimmoun, A.; Novy, E.; Auchet, T.; Ducrocq, N.; Levy, B. Hemodynamic Consequences of Severe Lactic Acidosis in Shock States: From Bench to Bedside. Crit. Care 2015, 19, Art. No: 175. DOI: 10.1186/s13054-015-0896-7.

Chua, H.R.; Schneider, A.; Bellomo, R. Bicarbonate in Diabetic Ketoacidosis—A Systematic Review. Ann. Intensive Care 2011, 1, 23. DOI: 10.1186/2110-5820-1-23.

Cox, K.; Cocchi, M.N.; Salciccioli, J.D.; Carney, E.; Howell, M.; Donnino, M.W. Prevalence and Significance of Lactic Acidosis in Diabetic Ketoacidosis. J. Crit. Care 2012, 27, 132-137. DOI: 10.1016/j.jcrc.2011.07.071.

Abuelo, J.G. Treatment of Severe Hyperkalemia: Confronting Four Fallacies. Kidney Int. Rep. 2017, 3, 47-55. DOI: 10.1016/j.ekir.2017.10.001.

Blumberg, A.; Weidmann, P.; Shaw, S.; Gnädinger, M. Effect of Various Therapeutic Approaches on Plasma Potassium and Major Regulating Factors in Terminal Renal Failure. Am. J. Med. 1988, 85, 507-512. DOI: 10.1016/s0002-9343(88)80086-x.

Allon, M.; Shanklin, N. Effect of Bicarbonate Administration on Plasma Potassium in Dialysis Patients: Interactions with Insulin and Albuterol. Am. J. Kidney Dis. 1996, 28, 508-514. DOI: 10.1016/s0272-6386(96)90460-6.

Fraley, D.S.; Adler, S. Correction of Hyperkalemia by Bicarbonate Despite Constant Blood pH. Kidney Int. 1977, 12, 354-360. DOI: 10.1038/ki.1977.122.

Carvalhana, V.; Burry, L.; Lapinsky, S.E. Management of Severe Hyperkalemia Without Hemodialysis: Case Report and Literature Review. J. Crit. Care 2006, 21, 316-321. DOI: 10.1016/j.jcrc.2005.10.001.

Adrogué, H.J.; Madias, N.E. Changes in Plasma Potassium Concentration During Acute Acid-Base Disturbances. Am. J. Med. 1981, 71, 456-467. DOI: 10.1016/0002-9343(81)90182-0.

Allon, M. Hyperkalemia in End-Stage Renal Disease: Mechanisms and Management. J. Am. Soc. Nephrol. 1995, 6, 1134-1142. DOI: 10.1681/ASN.V641134.

Sterns, R.H.; Cox, M.; Feig, P.U.; Singer, I. Internal Potassium Balance and the Control of the Plasma Potassium Concentration. Medicine (Baltimore) 1981, 60, 339-354. DOI: 10.1097/00005792-198109000-00002.

Bourdeaux, C.; Brown, J. Sodium Bicarbonate Lowers Intracranial Pressure After Traumatic Brain Injury. Neurocrit. Care 2010, 13, 24-28. DOI: 10.1007/s12028-010-9368-8.

Timofeev, I.; Nortje, J.; Al-Rawi, P.G.; Hutchinson, P.J.; Gupta, A.K. Extracellular Brain pH With or Without Hypoxia Is a Marker of Profound Metabolic Derangement and Increased Mortality After Traumatic Brain Injury. J. Cereb. Blood Flow Metab. 2013, 33, 422-427. DOI: 10.1038/jcbfm.2012.186.

Lopez-Rodriguez, A.B.; Acaz-Fonseca, E.; Viveros, M.P.; Garcia-Segura, L.M. Changes in Cannabinoid Receptors, Aquaporin 4 and Vimentin Expression After Traumatic Brain Injury in Adolescent Male Mice. PLoS One 2015, 10, Art. No: e0128782. DOI: 10.1371/journal.pone.0128782.

Asgari, N.; Berg, C.T.; Mørch, M.T.; Khorooshi, R.; Owens, T. Cerebrospinal Fluid Aquaporin-4-Immunoglobulin G Disrupts Blood Brain Barrier. Ann. Clin. Transl. Neurol. 2015, 2, 857-863. DOI: 10.1002/acn3.221.

Velissaris, D.; Karamouzos, V.; Ktenopoulos, N.; Pierrakos, C.; Karanikolas, M. The Use of Sodium Bicarbonate in the Treatment of Acidosis in Sepsis: A Literature Update on a Long-Term Debate. Crit. Care. Res. Pract. 2015, 2015, Art. No: 605830. DOI: 10.1155/2015/605830.

Zhang, Z.; Zhu, C.; Mo, L.; Hong, Y. Effectiveness of Sodium Bicarbonate Infusion on Mortality in Septic Patients with Metabolic Acidosis. Intensive Care Med. 2018, 44, 1888-1895. DOI: 10.1007/s00134-018-5379-2.

Jaber, S.; Paugam, C.; Futier, E.; Lefrant, J.Y.; Lasocki, S.; Lescot, T.; Pottecher, J.; Demoule, A.; Ferrandière, M.; Asehnoune, K.; Dellamonica, J.; Velly, L.; Abback, P.S.; de Jong, A.; Brunot, V.; Belafia, F.; Roquilly, A.; Chanques, G.; Muller, L.; Constantin, J.M.; Bertet, H.; Klouche, K.; Molinari, N.; Jung, B. Sodium Bicarbonate Therapy for Patients with Severe Metabolic Acidaemia in the Intensive Care Unit (BICAR-ICU): A Multicentre, Open-Label, Randomised Controlled, Phase 3 Trial. Lancet 2018, 392, 31-40. DOI: 10.1016/S0140-6736(18)31080-8.

Glaser, N.; Barnett, P.; McCaslin, I.; Nelson, D.; Trainor, J.; Louie, J.; Kaufman, F.; Quayle, K.; Roback, M.; Malley, R.; Kuppermann, N.; Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. Risk Factors for Cerebral Edema in Children with Diabetic Ketoacidosis. N. Engl. J. Med. 2001, 344, 264-269. DOI: 10.1056/NEJM200101253440404.

Lawrence, S.E.; Cummings, E.A.; Gaboury, I.; Daneman, D. Population-Based Study of Incidence and Risk Factors for Cerebral Edema in Pediatric Diabetic Ketoacidosis. J. Pediatr. 2005, 146, 688-692. DOI: 10.1016/j.jpeds.2004.12.041.

Edge, J.A.; Jakes, R.W.; Roy, Y.; Hawkins, M.; Winter, D.; Ford-Adams, M.E.; Murphy, N.P.; Bergomi, A.; Widmer, B.; Dunger, D.B. The UK Case-Control Study of Cerebral Oedema Complicating Diabetic Ketoacidosis in Children. Diabetologia 2006, 49, 2002-2009. DOI: 10.1007/s00125-006-0363-8.

Gamba, G.; Oseguera, J.; Castrejón, M.; Gómez-Pérez, F.J. Bicarbonate Therapy in Severe Diabetic Ketoacidosis. A Double Blind, Randomized, Placebo Controlled Trial. Rev. Invest. Clin. 1991, 43, 234-238.

Lever, E.; Jaspan, J.B. Sodium Bicarbonate Therapy in Severe Diabetic Ketoacidosis. Am. J. Med. 1983, 75, 263-8. DOI: 10.1016/0002-9343(83)91203-2.

Hale, P.J.; Crase, J.; Nattrass, M. Metabolic Effects of Bicarbonate in the Treatment of Diabetic Ketoacidosis. Br. Med. J. (Clin. Res. Ed.) 1984, 289, 1035-1038. DOI: 10.1136/bmj.289.6451.1035.

Kitabchi, A.E.; Umpierrez, G.E.; Miles, J.M.; Fisher, J.N. Hyperglycemic Crises in Adult Patients with Diabetes. Diabetes Care 2009, 32, 1335-1343. DOI: 10.2337/dc09-9032.

Umpierrez, G.E.; Davis, G.M.; ElSayed, N.A.; Fadini, G.P.; Galindo, R.J.; Hirsch, I.B.; Klonoff, D.C.; McCoy, R.G.; Misra, S.; Gabbay, R.A.; Bannuru, R.R.; Dhatariya, K.K. Hyperglycaemic Crises in Adults with Diabetes: A Consensus Report. Diabetologia 2024, 67(8),1455-1479. DOI: 10.1007/s00125-024-06183-8.

Okuda, Y.; Adrogue, H.J.; Field, J.B.; Nohara, H.; Yamashita, K. Counterproductive Effects of Sodium Bicarbonate in Diabetic Ketoacidosis. J. Clin. Endocrinol. Metab. 1996, 81, 314-320. DOI: 10.1210/jcem.81.1.8550770.

Ngugi, N.N.; McLigeyo, S.O.; Kayima, J.K. Treatment of Hyperkalaemia by Altering the Transcellular Gradient in Patients with Renal Failure: Effect of Various Therapeutic Approaches. East. Afr. Med. J. 1997, 74, 503-509.

Schwarz, K.C.; Cohen, B.D.; Lubash, G.D.; Rubin, A.L. Severe Acidosis and Hyperpotassemia Treated with Sodium Bicarbonate Infusion. Circulation 1959, 19, 215-220. DOI: 10.1161/01.cir.19.2.215.

Kimmoun, A.; Ducrocq, N.; Sennoun, N.; Issa, K.; Strub, C.; Escanyé, J.M.; Leclerc, S.; Levy, B. Efficient Extra- and Intracellular Alkalinization Improves Cardiovascular Functions in Severe Lactic Acidosis Induced by Hemorrhagic Shock. Anesthesiology 2014, 120, 926-934. DOI: 10.1097/ALN.0000000000000077.

Qureshi, A.I.; Suarez, J.I.; Bhardwaj, A.; Mirski, M.; Schnitzer, M.S.; Hanley, D.F.; Ulatowski, J.A. Use of Hypertonic (3%) Saline/Acetate Infusion in the Treatment of Cerebral Edema: Effect on Intracranial Pressure and Lateral Displacement of the Brain. Crit. Care Med. 1998, 26, 440-446. DOI: 10.1097/00003246-199803000-00011.

Qureshi, A.I.; Suarez, J.I.; Castro, A.; Bhardwaj, A. Use of Hypertonic Saline/Acetate Infusion in Treatment of Cerebral Edema in Patients with Head Trauma: Experience at a Single Center. J. Trauma 1999, 47, 659-665. DOI: 10.1097/00005373-199910000-00009.

Ichai, C.; Armando, G.; Orban, J.C.; Berthier, F.; Rami, L.; Samat-Long, C.; Grimaud, D.; Leverve, X. Sodium Lactate Versus Mannitol in the Treatment of Intracranial Hypertensive Episodes in Severe Traumatic Brain-Injured Patients. Intensive Care Med. 2009, 35, 471-479. DOI: 10.1007/s00134-008-1283-5.

Haase, M.; Haase-Fielitz, A.; Plass, M.; Kuppe, H.; Hetzer, R.; Hannon, C.; Murray, P.T.; Bailey, M.J.; Bellomo, R.; Bagshaw, S.M. Prophylactic Perioperative Sodium Bicarbonate to Prevent Acute Kidney Injury Following Open Heart Surgery: A Multicenter Double-Blinded Randomized Controlled Trial. PLoS Med. 2013, 10, e1001426. DOI: 10.1371/journal.pmed.1001426.

Anna Lis

lis.anna9898@gmail.com

Affiliation:

a:1:{s:5:"en_US";s:132:"Leszek Giec Upper- Silesian Medical Centre of the Medical University of Silesia in Katowice, Ziołowa 45/47, 40-635 Katowice, Poland";} Poland

Paulina Lis

lispaulinab@gmail.com

Affiliation:

Leszek Giec Upper- Silesian Medical Centre of the Medical University of Silesia in Katowice, Ziołowa 45/47, 40-635 Katowice, Poland Poland

Wojciech Kaźmierski

wkazmierski97@gmail.com

Affiliation:

Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, 30-705 Krakow, Poland Poland

Kinga Kocur

kingakocur98@wp.pl

Affiliation:

District Hospital st.Maximilian in Oświęcim, Wysokie Brzegi 4, 32-600 Oświęcim, Poland Poland

Katarzyna Camlet

katarzyna.camlet@gmail.com

Affiliation:

District Hospital in Zakopane, Kamieniec 10, 34-500 Zakopane, Poland Poland

Jakub Jurek

kubajurek1999@gmail.com

Affiliation:

Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, 30-705 Krakow, Poland Poland

Mateusz Ziomek

mateusz.ziomek98@gmail.com

Affiliation:

Military Institute of Medicine - National Research Institute, Szaserów 128, 04-141 Warsaw, Poland Poland

Anna Ziobro

aannaziobro@gmail.com

Affiliation:

District Hospital in Zakopane, Kamieniec 10, 34-500 Zakopane, Poland Poland

Sodium bicarbonate - known medication, new prospects?

Anna Lis

Paulina Lis

Wojciech Kaźmierski

Kinga Kocur

Katarzyna Camlet

Jakub Jurek

Mateusz Ziomek

Anna Ziobro

Abstract

Keywords:

Most read articles by the same author(s)

Similar Articles

Anna Lis

Paulina Lis

Wojciech Kaźmierski

Kinga Kocur

Katarzyna Camlet

Jakub Jurek

Mateusz Ziomek

Anna Ziobro